Snapshot

The Reliance Pathway pathway has been developed by the of Madagascar.

This pathway can be used where pharmaceutical products (new chemical entities, biologicals, vaccines), and medical devices (IVDs and male condoms).

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is 3 months (90 days).